The number of COVID-19 indicated medical devices gaining approval in Q2 2021 saw a 3% drop when compared with Q1 2021, according to GlobalData’s medical devices marketed products database
Compared with Q2 2020, the number of COVID-19 indicated medical devices gaining approval in Q2 2021 saw an 80% drop globally.
Comparing COVID-19 medical device approvals activity in different regions of the globe, North America held the top position for approved products (44%) in Q2 2021, followed by Europe (35%), and Asia-Pacific (20%).
